Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Third Amended and Restated Certificate of Incorporation of Os Therapies Incorporated
- 3.2 Form of Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Os Therapies Incorporated
- 3.3 Amended and Restated Bylaws of Os Therapies Incorporated
- 4.1 Specimen Common Stock Certificate
- 4.2 Form of Representative's Warrant
- 4.3 Form of Placement Agent Warrant (Group B Convertible Notes Placement)
- 4.4 Form of Placement Agent Warrant (Group C Convertible Notes Placement)
- 4.5 Form of Placement Agent Warrant (Group D Convertible Notes Placement)
- 5.1 Opinion of Olshan Frome Wolosky LLP, As to the Legality of the Common Stock
- 10.1 Form of Group a Convertible Note
- 10.2 Form of Group B Convertible Note
- 10.3 Form of Group C Convertible Note
- 10.4 Form of Groups D, E and F Convertible Note
- 10.5 Amended and Restated Development, License and Supply Agreement, Dated As of November 13, 2020, by and Between Os Therapies Incorporated and Advaxis, Inc. (Now Ayala Pharmaceuticals, Inc.)
- 10.5 First Amendment to Amended and Restated Development, License and Supply Agreement, Dated As of April 23, 2021, Between Os Therapies Incorporated and Advaxis, Inc. (Now Ayala Pharmaceuticals, Inc.)
- 10.6 License Agreement, Dated As of August 19, 2020, by and Between Os Therapies Incorporated and Blinkbio, Inc
- 10.7 Employment Agreement, Dated As of February 21, 2023, Between Os Therapies Incorporated and Paul A. Romness, MPH
- 10.8 Employment Letter, Dated June 23, 2020, Between Os Therapies Incorporated and Robert G. Petit, PH.D
- 10.10 Form of Indemnification Agreement Between Os Therapies Incorporated and Each of Its Directors
- 10.11 Os Therapies Incorporated 2023 Incentive Compensation Plan
- 10.11 Form of First Amendment to the Os Therapies Incorporated 2023 Incentive Compensation Plan
- 10.12 Employment Letter, Dated January 1, 2023, Between Os Therapies Incorporated and Christopher P. Acevedo
- 23.1 Consent of Malonebailey, LLP, Independent Registered Public Accounting Firm
- EX-FILING FEES Calculation of Filing Fee Table
Associated filings
OSTX similar filings
Filing view
External links